SELECTED M&A EXPERIENCE

  
 

 
 
Sale to Entelos   $215 million
Sale of Phase II-IV Division to Kendle
Sole Advisor		   $ 9.9 billion
Acquisition of IVAX		   $220 million
Merger with BioSearch Italia		   ~ $350 million
Merger with Oxford Asymmetry		   $1,696 million
Sale to Invitrogen
         
Aug 2007   May 2006   Jan 2006   Announced July 2002 /
Closed Mar 2003		   Dec. 2000   Sept. 2000
$135 million
Acquisition of Diatide		   Sale of Interest in Tecan   $335 million
Alliance with Abbott Labs		   $728 million
Sale to Pharmacia & Upjohn		   $210 million
Acquisition of Autonomous Tech.		   Sale to T Cell Sciences
         
Oct. 1999   Oct. 1999   Aug. 1999   Aug. 1999   Oct. 1998   May 1998
$33 million
Acquisition of IMTIX		   Sale to the Marmon Group   Sale to Pharmaceutical
Research Associates 		   $65 million
Acquisition of GenPharm 		   Sale to Genzyme     
           
Apr. 1998   Dec. 1997   May 1997    May 1997    Nov. 1996     
 
 
   
 
 

* Includes clients while at other firms

  
 

 

 

  
 

 

 

* Member FINRA and SIPC